UNSPSC 51287002: Acetosulfone or sulfadiasulfone

This classification denotes a sulfone anti-infective agent with the molecular formula C14H14N3O5S2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FQ3M2Y4BU3, chemically known as 4, 4-diaminodiphenylsulfone-2-n-acetylsulfonamide, but more generally known as acetosulfone, which bears US NIH Compound Identifier 31400. European Medicines Agency schedules Sulfadiasulfone sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04621MIG.

The term SULFADIASULFONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, No. 3 1962, List 4). SMILES: S(=O)(=O)(C1C(S(=O)(=O)NC(=O)C)CC(N)CC1)C1CCC(N)CC1.

UNSPSC 51287002 Acetosulfone or sulfadiasulfone is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal scope. The two most-recent opportunities tagged to this code—a pharmaceutical warehouse piggyback contract awarded by the Illinois Department of Public Health for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida IFB for Naloxone and drug deactivation systems—represent antibiotic and emergency-response pharmaceuticals rather than acetosulfone or sulfadiasulfone compounds specifically. Neither solicitation describes procurement of the sulfone-class compounds the code nominally covers, suggesting either a classification mismatch in the underlying data or extremely sparse recent demand for this specific pharmaceutical under state and local procurement channels.

The Illinois Department of Public Health and Seminole County, Florida are the issuing bodies identified in the recent record, representing state-level health procurement and county-level community health initiatives respectively. The Illinois contract, awarded to Chartwell Rx LLC on August 28, 2026, totaled $2,999,999.11 over 12 months with renewal options for years 2 and 3; Seminole County's IFB, posted June 30, 2026 with a July 26, 2026 response deadline, sought annual quantities of 1,900 units of Naloxone and 800 drug deactivation systems with quarterly deliveries. No evidence of recent acetosulfone-specific procurement appears in the available opportunities, and business development professionals should verify whether this code represents active demand in their target markets or whether opportunities tagged here are consistently misclassified.